HTS13286 is a novel AQP9 inhibitor. HTS13286 prevents the LPS-induced increase of NO . HTS13286 reduces glucose output. HTS13286 can be used in the research of endotoxin shock.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Aquaporin | Products > Signaling Pathways > NO Synthase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.